Lung Cancer Research: Lancet Oncology | Dana-Farber Cancer Institute
🛍️ Products Mentioned (1)
A study in Lancet Oncology shows how Dana-Farber research, led by Dr. Biagio Ricciuti, found dual immunotherapy may help certain patients with advanced non-small cell lung cancer live longer. Read more: https://bit.ly/49K4uUp
🎬 More from Dana-Farber Cancer Institute
Understanding Chemo Neuropathy: A Webinar by the Older Adults with GI Cancer Program | Dana-Farber
19 views
Learning About Chronic Lymphocytic Leukemia | Lymph Notes: A Lymphoma Learning Series
112 views
ASCO26: David Reardon, MD Glioblastoma Vaccine | Dana-Farber Cancer Institute
106 views
Society of Gynaecological Oncology Congress 2026: Tara Berman, MD | Dana-Farber Cancer Institute
30 views
ASCO26: Julia Rotow, MD Silevertinib in Lung Cancer | Dana-Farber Cancer Institute
55 views
ASCO26: Atish Choudhury, MD, PhD A-DREAM/Alliance A032101 | Dana-Farber Cancer Institute
38 views